Vaxcyte, Inc. (PCVX)
58.13
-2.24
(-3.71%)
USD |
NASDAQ |
Sep 18, 16:00
58.14
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Price : 58.13 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 60.37 | 60.37 | 57.01 | 58.13 | 2.717M |
| Sep 17, 2026 | 60.22 | 61.50 | 59.31 | 60.37 | 1.309M |
| Sep 16, 2026 | 59.25 | 60.13 | 58.40 | 58.77 | 1.249M |
| Sep 15, 2026 | 59.70 | 59.75 | 58.18 | 59.21 | 1.888M |
| Sep 14, 2026 | 60.04 | 60.85 | 59.08 | 59.54 | 1.428M |
| Sep 11, 2026 | 60.07 | 60.20 | 58.21 | 59.47 | 1.683M |
| Sep 10, 2026 | 59.19 | 60.13 | 58.56 | 58.90 | 1.161M |
| Sep 09, 2026 | 59.99 | 60.33 | 59.04 | 59.51 | 1.195M |
| Sep 08, 2026 | 60.25 | 61.03 | 59.22 | 60.36 | 1.024M |
| Sep 04, 2026 | 59.73 | 61.78 | 59.64 | 61.16 | 986707.0 |
| Sep 03, 2026 | 61.73 | 62.14 | 59.85 | 61.17 | 736473.0 |
| Sep 02, 2026 | 61.63 | 62.90 | 60.82 | 61.58 | 1.021M |
| Sep 01, 2026 | 60.29 | 62.14 | 60.06 | 60.81 | 1.441M |
| Aug 31, 2026 | 59.10 | 61.61 | 58.51 | 60.74 | 1.749M |
| Aug 28, 2026 | 61.06 | 62.38 | 59.48 | 59.84 | 760160.0 |
| Aug 27, 2026 | 60.98 | 61.60 | 59.93 | 61.16 | 611753.0 |
| Aug 26, 2026 | 61.04 | 61.64 | 60.32 | 61.09 | 891704.0 |
| Aug 25, 2026 | 62.22 | 63.92 | 60.96 | 61.09 | 1.218M |
| Aug 24, 2026 | 62.30 | 63.05 | 61.23 | 61.87 | 662140.0 |
| Aug 21, 2026 | 61.60 | 63.98 | 61.60 | 62.62 | 1.142M |
| Aug 20, 2026 | 62.23 | 62.91 | 60.80 | 61.34 | 726436.0 |
| Aug 19, 2026 | 61.56 | 63.83 | 60.94 | 63.30 | 1.445M |
| Aug 18, 2026 | 59.97 | 60.86 | 59.50 | 59.79 | 705939.0 |
| Aug 17, 2026 | 58.03 | 60.29 | 57.34 | 60.22 | 712903.0 |
| Aug 14, 2026 | 58.11 | 58.74 | 57.30 | 58.07 | 656560.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 154.04 |
| Arrowhead Pharmaceuticals, Inc. | 66.48 |
| Oncolytics Biotech, Inc. | 0.77 |
| Sangamo Therapeutics, Inc. | 0.1449 |
| Sarepta Therapeutics, Inc. | 20.11 |
Price Related Metrics
| PEG Ratio | -0.0899 |
| Price to Book Value | 3.052 |
| Earnings Yield | -13.26% |
| Market Cap | 8.416B |
| PEGY Ratio | -0.0899 |